Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 1, 2021
Clear
SKU: GMS-1222 Category:

OVERVIEW

The Leukapheresis Market is expected to reach USD 32.94 million by 2026, growing at a CAGR of 7.36% during the forecast period. The rising demand for blood transfusions in patients with leukemia, lymphoma, and other blood disorders is said to contribute to the leukapheresis market growth. Blood donations have a short shelf life so regular supply of blood is required. Leukopaks are blood components procured from blood using leukapheresis. These blood components are required by patients who require such enriched blood cells. This demand for specific blood components will also contribute this market growth. With COVID-19 pandemic and possible resurge the hospitals are focussed on serving only the emergency cases and engage all of their resources in order to fight the coronavirus which has had an impact on the market growth.

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 1

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 2

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 3

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 4

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 5

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 6

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 7

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2021 to 2026 8

TABLE OF CONTENT

1 Global Leukapheresis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Leukapheresis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Leukapheresis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Leukapheresis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Leukapheresis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Leukapheresis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Leukapheresis Market – By Type (Market Size – & million/billion)
8.1 Leukapheresis Devices
8.2 Leukapheresis Disposables

9 Global Leukapheresis Market – By Application
9.1 Research Applications
9.2 Therapeutic Applications

10 Global Leukapheresis Market – By End-User
10.1 Blood Component Providers and Blood Centers
10.2 Academic and Research Institutes
10.3 Pharmaceutical and Biotechnology Companies
10.4 Hospitals and Transfusion Centers

11 Global Leukapheresis Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Leukapheresis Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Leukapheresis Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
13.3 Fresenius Se & Co. KGaA
13.4 Haemonetics Corporation
13.5 Hemacare Corporation
13.6 Key Biologics, LLC.
13.7 Stemcell Technologies, Inc.
13.8 Caltag Medsystems Limited
13.9 Terumo BCT
13.10 ALLCells, LLC.
13.11 Stemexpress, LLC.
13.12 Company 11 & more

14 Global Leukapheresis Market – Appendix
14.1 Sources
14.2 Abbreviations